Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA

Published:2021-11 Issue: Volume:135 Page:556-566
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Yuan Ye^ORCID,Liu Jia,Yu Xiangnan^ORCID,Liu Xingxin,Cheng Yanni,Zhou Cheng,Li Mingyi,Shi Lin,Deng Yan,Liu Huan,Wang Guobin,Wang Lin,Wang Zheng

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference37 articles.

1. International Agency for Research on Cancer, WHO. https://gco.iarc.fr/today/home (accessed February 17, 2021).

2. Breast cancer;Harbeck;Lancet,2017

3. A view on drug resistance in cancer;Vasan;Nature,2019

4. Revisiting the role of ABC transporters in multidrug-resistant cancer;Robey;Nat. Rev. Cancer,2018

5. The role of ABC transporters in clinical practice;Leonard;Oncologist,2003

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in small interfering RNA based therapeutic approach on breast cancer;European Journal of Pharmacology;2024-10

2. IF-7 and GALA modified PEG-PDMAEMA loaded SOX10 siRNA nanoparticles: Preparation, cellular delivery, and inhibition on progression of triple negative breast cancer and its bone metastasis in vitro;Journal of Drug Delivery Science and Technology;2024-10

3. Dendrimers as drug delivery systems for oncotherapy: Current status of promising applications;International Journal of Pharmaceutics;2024-09

4. Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release;Molecular Pharmaceutics;2024-07-26

5. Therapeutic regulation of epigenetics in cancer treatment through drug delivery systems;Nano Today;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3